New England Journal of Medicine· 2021Q1
Diffuse Large B-Cell Lymphoma
- 1,151citations
- Q1SCImago
- 2021year
Short summary
Diffuse Large B-Cell Lymphoma (DLBCL) is an aggressive cancer representing 30% of lymphomas, with current standard chemotherapy curing approximately 65% of patients initially and an additional 20-25% with salvage therapy.
AI-generated from the title and abstract; the full text is not read.
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Pathology and Forensic Medicine
Pathology and Forensic MedicineMedicine